医疗补助扩展对头颈恶性肿瘤就诊分期与生存的影响
研究利用监测、流行病学和最终结果数据库2010—2016年数据,回顾性分析医疗补助扩展对头颈鳞状细胞癌、分化型甲状腺癌及头颈皮肤黑色素瘤疾病特异性生存的影响。在采纳扩展的州,医疗补助与无保险患者比例由3:1升至9:1(p<0.001),未采纳州由1:1升至2:1(p<0.001)。采纳扩展州诊断的头颈鳞状细胞癌患者扩展前生存更差(HR 1.24,95%CI 1.11—1.39,p<0.001)。
要点
- 采纳医疗补助扩展的州医疗补助与无保险患者比例由3:1升至9:1(p<0.001)。
- 未采纳扩展的州该比例由1:1升至2:1(p<0.001),扩展州覆盖增幅显著更高(p<0.001)。
- 采纳扩展州头颈鳞状细胞癌患者扩展前诊断者生存更差(HR 1.24,95%CI 1.11—1.39,p<0.001)。
核心结论
- 早期数据表明实施《平价医疗法案》改善了头颈鳞状细胞癌患者的疾病特异性生存。
研究设计与样本
- 回顾性研究,利用监测、流行病学和最终结果数据库2010—2016年数据。
- 研究人群包括头颈鳞状细胞癌、分化型甲状腺癌及头颈皮肤黑色素瘤患者。
- 目的是比较医疗补助扩展前后疾病特异性生存。
主要发现
- 采纳扩展的州医疗补助与无保险患者比例由3:1升至9:1(p<0.001)。
- 未采纳扩展的州该比例由1:1升至2:1(p<0.001)。
- 采纳扩展州医疗补助覆盖增幅显著高于未采纳州(p<0.001)。
- 采纳扩展州头颈鳞状细胞癌患者扩展前诊断者生存更差(HR 1.24,95%CI 1.11—1.39,p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Under the Affordable Care Act (ACA), Medicaid expansion became effective in states that have adopted it. We aim to examine its impact on head and neck cancers. METHODS: A retrospective study that utilizes the Surveillance, Epidemiology, and End Results database, 2010-2016. Study population included patients with head and neck squamous cell carcinoma (HNSCC), differentiated thyroid carcinoma, and head and neck cutaneous melanoma. The objective is to examine disease-specific survival before and after Medicaid expansion. RESULTS: In states that adopted Medicaid expansion, the ratio of Medicaid: uninsured patients increased from 3:1 to 9:1 (p < 0.001). In states that did not adopt Medicaid expansion, the ratio increased from 1:1 to 2:1 (p < 0.001), making the increase in Medicaid coverage in states that adopted the expansion significantly higher (p < 0.001). Patients diagnosed with HNSCC before the expansion had worse survival (hazard ratio [HR]: 1.24, 95% confidence interval: 1.11, 1.39, p < 0.001) in states that adopted Medicaid expansion. CONCLUSIONS: Early data indicate that implementation of ACA improved disease-specific survival of patients with HNSCC. LEVEL OF EVIDENCE: 3 Laryngoscope, 133:1409-1414, 2023.
引用
- Al-Qurayshi Z, Sullivan CB, Shama MA, et al. The Impact of Medicaid Expansion on Head and Neck Malignancies Presentation and Survival. Laryngoscope. 2022. PMID: 37158264. doi:10.1002/lary.30314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。